{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:25:33Z","timestamp":1787585133619,"version":"build-2736575974"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"\n Background<\/jats:title>\n Major depressive disorder (MDD) is a leading cause of disability globally, with high relapse rates. Currently, there is no standardized consensus on administrative criteria for defining relapses in MDD.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n A comprehensive literature search was conducted for texts published from January 1980 to April 2026. Articles were included if they described a depressive episode\/major depressive episode or unipolar depression. The initial electronic search identified 4148 documents, and 51 were finally included in this review.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Over two thirds of the articles focus directly on relapse of MDD, either describing the overall prognosis of the disorder in various populations, the outcome of a given intervention, or the impact of certain factors. 44 of the 51 articles provide a definition of relapse based on either clinical criteria, psychometric measures or what we will establish as administrative criteria. Among those who use scales for definition there is not much uniformity. Among the administrative criteria the most cited is hospitalization, followed by changes in treatment and the need for electroconvulsive therapy.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n We suggest a conceptual model based on these criteria to define relapse in depression by drawing some preliminary conclusions: A minimum period of time from the remission of the previous episode to the emergence of what is considered a relapse is necessary, as well as the presence of at least one high-specificity criterion\u2014hospitalization (including emergency room visit), ECT, or suicide attempt\u2014and, in a complementary role, structured pharmacological changes that reflect guideline-based therapeutic steps.<\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fpsyt.2026.1796386","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T09:34:47Z","timestamp":1787045687000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Administrative criteria in the relapse of depressive disorder: a critical appraisal"],"prefix":"10.3389","volume":"17","author":[{"given":"Sara","family":"Bernal-Cueto","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Jimenez Diaz Foundation Hospital","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Cegla-Schvartzman","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Jimenez Diaz Foundation Hospital","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Baca-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Jimenez Diaz Foundation Hospital","place":["Madrid, Spain"]},{"name":"Instituto de Investigaci\u00f3n Sanitario de la Fundaci\u00f3n Jim\u00e9nez D\u00edaz","place":["Madrid, Spain"]},{"name":"Department of Psychiatry, Universidad Aut\u00f3noma de Madrid","place":["Madrid, Spain"]},{"name":"Department of Psychiatry, Rey Juan Carlos University Hospital, M\u00f3stoles","place":["Madrid, Spain"]},{"name":"Department of Psychiatry, General Hospital of Villalba","place":["Madrid, Spain"]},{"name":"Department of Psychiatry, Infanta Elena University Hospital, Valdemoro","place":["Madrid, Spain"]},{"name":"Department of Psychology, Universidad Cat\u00f3lica de Maule","place":["Talca, Chile"]},{"name":"Department of Psychiatry, Centre Hospitalier Universitaire de N\u00eemes","place":["N\u00eemes, France"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Salud Mental (CIBERSAM), Research Group CB\/07\/09\/0025","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12888-022-03793-7","article-title":"Incremental burden of relapse in patients with major depressive disorder: a real-world, retrospective cohort study using claims data","volume":"22","author":"Touya","year":"2022","journal-title":"BMC Psychiatry"},{"key":"B2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1080\/21556660.2019.1612410","article-title":"Economic burden of relapse\/recurrence in patients with major depressive disorder","volume":"8","author":"Gauthier","year":"2019","journal-title":"J Drug Assess"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1046\/j.1600-0447.2003.00266.x","article-title":"The predictive effect of episodes on the risk of recurrence in depressive and bipolar disorders \u2013 a life\u2010long perspective","volume":"109","author":"Kessing","year":"2004","journal-title":"Acta Psychiatr Scand"},{"key":"B4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0165-0327(86)90050-9","article-title":"A two-year naturalistic follow-up of depressed patients treated with cognitive therapy, pharmacotherapy and a combination of both","volume":"10","author":"Blackburn","year":"1986","journal-title":"J Affect Disord"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1991.01810330075011","article-title":"Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence","volume":"48","author":"Frank","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2019.11.105","article-title":"The role of relapse prevention for depression in collaborative care: a systematic review","volume":"265","author":"Moriarty","year":"2020","journal-title":"J Affect Disord"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004692.pub5","article-title":"Omega-3 fatty acids for depression in adults","volume":"11","author":"Appleton","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.4045\/tidsskr.10.1349","article-title":"Relapse following electroconvulsive therapy","volume":"131","author":"Moksnes","year":"2011","journal-title":"Tidsskr Nor Laegeforen"},{"key":"B9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/s0165-0327(99)00127-5","article-title":"Reconfirming the role of life events for the timing of depressive episodes","volume":"59","author":"Mundt","year":"2000","journal-title":"J Affect Disord"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/s0165-0327(99)00086-5","article-title":"Remission onset and relapse in depression. An 18-month prospective study of course for 100 first admission patients","volume":"57","author":"O\u2019Leary","year":"2000","journal-title":"J Affect Disord"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1037\/\/0021-843x.98.3.229","article-title":"Predictors of relapse in unipolar depressives: Expressed emotion, marital distress, and perceived criticism","volume":"98","author":"Hooley","year":"1989","journal-title":"J Abnorm Psychol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.148.6.642","article-title":"Levels of expressed emotion and relapse in depressed patients","volume":"148","author":"Hooley","year":"1986","journal-title":"Br J Psychiatry"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/acps.13183","article-title":"Comparison of the efficacy of electroconvulsive therapy (ECT) plus agomelatine to ECT plus placebo in treatment\u2010resistant depression","volume":"142","author":"Lin","year":"2020","journal-title":"Acta Psychiatr Scand"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1097\/YCT.0000000000000619","article-title":"Risk factors of relapse after successful electroconvulsive therapy for Taiwanese patients with major depression","volume":"36","author":"Yang","year":"2020","journal-title":"J ECT"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/da.22872","article-title":"Relapse prevention with levomilnacipran ER in adults with major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study","volume":"36","author":"Durgam","year":"2019","journal-title":"Depress Anxiety"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2015.05.022","article-title":"Relapse and long-term cognitive performance after brief pulse or ultrabrief pulse right unilateral electroconvulsive therapy: a multicenter naturalistic follow up","volume":"184","author":"Verwijk","year":"2015","journal-title":"J Affect Disord"},{"key":"B17","first-page":"17","article-title":"Long-term follow-up of MDD patients who respond to deep rTMS: a brief report","volume":"52","author":"Rosenberg","year":"2015","journal-title":"Isr J Psychiatry Relat Sci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.12m07974","article-title":"Efficacy and safety of desvenlafaxine 50 mg\/d for prevention of relapse in major depressive disorder: a randomized controlled trial","volume":"74","author":"Rosenthal","year":"2013","journal-title":"J Clin Psychiatry"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jagp.2022.05.010","article-title":"Long-term outcome following electroconvulsive therapy for late-life depression: five-year follow-up data from the MODECT study","volume":"30","author":"Lambrichts","year":"2022","journal-title":"Am J Geriatr Psychiatry"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2021.09.006","article-title":"Depression and inflammation: correlation between changes in inflammatory markers with antidepressant response and long-term prognosis","volume":"54","author":"Kofod","year":"2022","journal-title":"Eur Neuropsychopharmacol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/YCT.0000000000000785","article-title":"Discontinuation of continuation or maintenance electroconvulsive therapy caused by the COVID-19 pandemic: a naturalistic study investigating relapse in patients with major depressive disorder","volume":"37","author":"Van de Velde","year":"2021","journal-title":"J ECT"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0222791","article-title":"The epidemiology of antidepressant use in South Korea: does short-term antidepressant use affect the relapse and recurrence of depressive episodes","volume":"14","author":"Kim","year":"2019","journal-title":"PloS One"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1097\/YCT.0000000000000271","article-title":"Effect of age on psychiatric rehospitalization rates after electroconvulsive therapy for patients with depression","volume":"32","author":"Rosen","year":"2016","journal-title":"J ECT"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/YCT.0000000000000164","article-title":"Improving relapse prevention after successful electroconvulsive therapy for patients with severe depression: completed audit cycle involving 102 full electroconvulsive therapy courses in West Sussex, United Kingdom","volume":"31","author":"Atiku","year":"2015","journal-title":"J ECT"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032950","article-title":"The effects of centralised and specialised intervention in the early course of severe unipolar depressive disorder: a randomised clinical trial","volume":"7","author":"Hansen","year":"2012","journal-title":"PloS One"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2011.02.016","article-title":"The effects of continuous antidepressant treatment during the first 6 months on relapse or recurrence of depression","volume":"132","author":"Kim","year":"2011","journal-title":"J Affect Disord"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.55.12.1128","article-title":"The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression","volume":"55","author":"Melfi","year":"1998","journal-title":"Arch Gen Psychiatry"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.169.4.423","article-title":"Seven year prognosis in depression. Mortality and readmission risk in the Nottingham ECT cohort","volume":"169","author":"O\u2019Leary","year":"1996","journal-title":"Br J Psychiatry"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1177\/089198879100400308","article-title":"Hospital utilization and readmission rates for geriatric and young adult patients with major depression: results from a historical cohort study","volume":"4","author":"Colenda","year":"1991","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201600192","article-title":"Increased treatment complexity for major depressive disorder for inpatients with comorbid personality disorder","volume":"68","author":"Wiegand","year":"2017","journal-title":"Psychiatr Serv"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1001\/jama.2021.21187","article-title":"Effect of long-term supplementation with marine omega-3 fatty acids vs placebo on risk of depression or clinically relevant depressive symptoms and on change in mood scores: a randomized clinical trial","volume":"326","author":"Okereke","year":"2021","journal-title":"JAMA"},{"key":"B32","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1001\/jama.2020.10224","article-title":"Effect of long-term vitamin D3 supplementation vs placebo on risk of depression or clinically relevant depressive symptoms and on change in mood scores: a randomized clinical trial","volume":"324","author":"Okereke","year":"2020","journal-title":"JAMA"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1097\/01.yic.0000199452.16682.b8","article-title":"Response, remission and relapse in relation to adherence in primary care treatment of depression: a 2-year outcome study","volume":"21","author":"\u00c5kerblad","year":"2006","journal-title":"Int Clin Psychopharmacol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1996.01830090013002","article-title":"Maintenance therapy for chronic depression. A controlled clinical trial of desipramine","volume":"53","author":"Kocsis","year":"1996","journal-title":"Arc Gen Psychiatry"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2021.09.010","article-title":"ADHD in adults with recurrent depression","volume":"295","author":"Powell","year":"2021","journal-title":"J Affect Disord"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1097\/YCT.0000000000000693","article-title":"Recurrence after stopping maintenance electroconvulsive therapy: a retrospective case series","volume":"36","author":"Cabelguen","year":"2020","journal-title":"J ECT"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.08m04548","article-title":"Agomelatine prevents relapse in patients with major depressive disorder without evidence of a discontinuation syndrome: a 24-week randomized, double-blind, placebo-controlled trial","volume":"70","author":"Goodwin","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2003.09.015","article-title":"Effectiveness of electroconvulsive therapy in community settings","volume":"55","author":"Prudic","year":"2004","journal-title":"Biol Psychiatry"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1159\/000075186","article-title":"Subtypes of depressive episodes according to ICD-10: prediction of risk of relapse and suicide","volume":"36","author":"Kessing","year":"2003","journal-title":"Psychopathology"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/gps.671","article-title":"Prophylactic therapy with lithium in elderly patients with unipolar major depression","volume":"17","author":"Wilkinson","year":"2002","journal-title":"Int J Geriatr Psychiatry"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2025.0200","article-title":"Esketamine combined with SSRI or SNRI for treatment-resistant depression","volume":"82","author":"Del Casale","year":"2025","journal-title":"JAMA Psychiatry"},{"key":"B42","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jad.2024.09.129","article-title":"The N-3 polyunsaturated fatty acids supplementation to prevent depression recurrence in patients with late-life depression: a 52-week double-blind, placebo-controlled trial","volume":"369","author":"Cheng","year":"2025","journal-title":"J Affect Disord"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.2024.124","article-title":"Efficacy of esketamine nasal spray over quetiapine extended release over the short and long term: sensitivity analyses of ESCAPE-TRD, a randomised phase IIIb clinical trial","volume":"226","author":"Young","year":"2025","journal-title":"Br J Psychiatry"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2025.120548","article-title":"The portable transcranial electrical stimulation and internet-based behavioral therapy for major depression study (PSYLECT): results of the maintenance phase","volume":"394","author":"Aparicio","year":"2026","journal-title":"J Affect Disord"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2025.4453","article-title":"One-year actigraphy study of sleep and rest-activity rhythms as markers of relapse in depression","volume":"83","author":"Tonon","year":"2026","journal-title":"JAMA Psychiatry"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2025.01.009","article-title":"Challenges in maintaining remission after ECT \u2013 insights from a six-month follow up study","volume":"182","author":"van Diermen","year":"2025","journal-title":"J Psychiatr Res"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2025-107051","article-title":"Efficacy, moderators and mediators of cognitive behavioural analysis system of psychotherapy (CBASP) versus behavioural activation (BA) in persistently depressed treatment-resistant inpatients: study protocol for the multicentre, randomised controlled changePDD trial","volume":"16","author":"Brakemeier","year":"2026","journal-title":"BMJ Open"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1177\/07067437251337603","article-title":"Predicting relapse of depressive episodes during maintenance treatment: the Canadian Biomarker Integration Network in Depression (CAN-BIND) wellness monitoring in major depressive disorder study","volume":"70","author":"Lam","year":"2025","journal-title":"Can J Psychiatry"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-024-02523-7","article-title":"Effect of olanzapine exposure on relapse and brain structure in patients with major depressive disorder with psychotic features","volume":"29","author":"Kim","year":"2024","journal-title":"Mol Psychiatry"},{"key":"B50","doi-asserted-by":"publisher","first-page":"121032","DOI":"10.1016\/j.jad.2025.121032","article-title":"The durability of response to transcranial magnetic stimulation in veterans with major depressive disorder","volume":"360","author":"Lisha","year":"2025","journal-title":"J Affect Disord"},{"key":"B51","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1080\/13651501.2025.2510244","article-title":"Development and validation of a predictive model for readmission of major depressive disorder patients with suicide attempts","volume":"29","author":"Hao","year":"2025","journal-title":"Int J Psychiatry Clin Pract"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-025-03746-0","article-title":"Real-world analysis of pharmacological treatments to prevent relapse after electroconvulsive therapy for major depressive disorder: a nationwide cohort study","volume":"15","author":"Kronsell","year":"2025","journal-title":"Transl Psychiatry"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1192\/j.eurpsy.2025.10145","article-title":"Modeling effect: how treatment intensity and duration impact depression recurrence","volume":"69","author":"Li","year":"2026","journal-title":"Eur Psychiatry"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2023.10.069","article-title":"Relevance between age of onset and hospitalization characteristics of major depressive disorders: a 16 years retrospective cohort study","volume":"344","author":"Yao","year":"2024","journal-title":"J Affect Disord"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1136\/bmjment-2023-300915","article-title":"Healthy lifestyle and the risk of depression recurrence requiring hospitalisation and mortality among adults with pre-existing depression: a prospective cohort study","volume":"27","author":"Cao","year":"2024","journal-title":"BMJ Ment Health"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.5756","article-title":"Management of depression in adults: a review","volume":"332","author":"Simon","year":"2024","journal-title":"JAMA"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1796386\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:38:54Z","timestamp":1787582334000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1796386\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":56,"alternative-id":["10.3389\/fpsyt.2026.1796386"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2026.1796386","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]},"article-number":"1796386"}}